Literature DB >> 8240157

Cyclophosphamide related hepatotoxicity.

B D Cleland, C S Pokorny.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8240157     DOI： 10.1111/j.1445-5994.1993.tb01447.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN： 0004-8291


× No keyword cloud information.
  5 in total

1.  Cyclophosphamide and fludarabine monophosphate dose optimization for the non-myeloablative condition in non-human primates to induce transient mixed chimerism via bone marrow transplantation.

Authors:  Yeongbeen Kwon; Kyo Won Lee; Hyojun Park; Jin Kyung Son; JongHyun Lee; Chan Woo Cho; Ghee Young Kwon; Jae Berm Park; Sung Joo Kim
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

2.  Reversible hepatic dysfunction in association with cyclophosphamide therapy.

Authors:  D V Milford; N Butler; R Clarke; J Vaid
Journal:  Eur J Pediatr       Date:  1995-05       Impact factor: 3.183

3.  High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702).

Authors:  Kellie J Nazemi; Violet Shen; Jonathan L Finlay; James Boyett; Mehmet Kocak; Deborah Lafond; Sharon L Gardner; Roger J Packer; H Stacy Nicholson
Journal:  Pediatr Blood Cancer       Date:  2016-05-20       Impact factor: 3.167

Review 4.  Cyclophosphamide-induced severe acute hepatitis in a rheumatic disease: case-based review.

Authors:  Döndü Üsküdar Cansu; Erkin Öztaş; Evrim Yilmaz; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2018-10-30       Impact factor: 2.631

5.  Low-dose cyclophosphamide-induced acute hepatotoxicity.

Authors:  S Ravih Subramaniam; Rizna Abdul Cader; Rozita Mohd; Kong Wei Yen; Halim Abdul Ghafor
Journal:  Am J Case Rep       Date:  2013-09-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.